- Home
- ALLR vs CREX Comparison
ALLR vs CREX Comparison
Compare ALLR & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- CREX
- Stock Information
- Founded
- ALLR 2004
- CREX N/A
- Country
- ALLR United States
- CREX United States
- Employees
- ALLR N/A
- CREX N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- CREX EDP Services
- Sector
- ALLR Health Care
- CREX Technology
- Exchange
- ALLR Nasdaq
- CREX Nasdaq
- Market Cap
- ALLR 21.8M
- CREX 25.7M
- IPO Year
- ALLR N/A
- CREX N/A
- Fundamental
- Price
- ALLR $1.42
- CREX $2.87
- Analyst Decision
- ALLR Strong Buy
- CREX Strong Buy
- Analyst Count
- ALLR 1
- CREX 1
- Target Price
- ALLR $9.25
- CREX $6.00
- AVG Volume (30 Days)
- ALLR 327.2K
- CREX 104.9K
- Earning Date
- ALLR 11-13-2025
- CREX 11-12-2025
- Dividend Yield
- ALLR N/A
- CREX N/A
- EPS Growth
- ALLR N/A
- CREX N/A
- EPS
- ALLR N/A
- CREX N/A
- Revenue
- ALLR N/A
- CREX $48,218,000.00
- Revenue This Year
- ALLR N/A
- CREX $4.82
- Revenue Next Year
- ALLR N/A
- CREX $18.60
- P/E Ratio
- ALLR N/A
- CREX N/A
- Revenue Growth
- ALLR N/A
- CREX N/A
- 52 Week Low
- ALLR $0.61
- CREX $1.28
- 52 Week High
- ALLR $2.35
- CREX $4.72
- Technical
- Relative Strength Index (RSI)
- ALLR 40.01
- CREX 74.32
- Support Level
- ALLR $1.40
- CREX $2.70
- Resistance Level
- ALLR $1.53
- CREX $3.00
- Average True Range (ATR)
- ALLR 0.12
- CREX 0.28
- MACD
- ALLR -0.03
- CREX 0.06
- Stochastic Oscillator
- ALLR 1.49
- CREX 94.93
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.